Articles

CG Life's New Chief Creative Officer: Implications for Pharma

CG Life has appointed Collette Douaihy as its new chief creative officer. This article explores the implications of this leadership change for the pharmaceutical sector.

LogiPharma Asia 2026: What to Expect from the Event

LogiPharma Asia 2026 is set to be a pivotal event for the pharmaceutical logistics sector. Attendees can expect insights into emerging trends and key players in the industry.

BeOne's 'One Save Changes Everything' Campaign: A New Era in Pharma Marketing

BeOne launches a transformative campaign with Tim Howard, aiming to reshape pharma marketing. Discover its potential impact on the industry.

Roche's Alecensa Expansion: Implications for Pharma Stakeholders

Roche's Alecensa has received approval for the treatment of all ALK tumor types in Japan, marking a significant regulatory milestone. This article explores the implications for pharma stakeholders.

Takeda's $885M Verdict: Implications for Pharma Business Strategies

Takeda faces an $885M verdict in a pay-for-delay antitrust case, raising significant questions for pharmaceutical business strategies and market dynamics.

Kelun-Biotech's SKB118 Receives CDE Approval: What Investors Need to Know

Kelun-Biotech has received Investigational New Drug approval for SKB118 from the CDE. This article explores the implications for investors and pharmaceutical teams.

Eli Lilly's Community Engagement: A Strategic Partnership with Caitlin Clark

Eli Lilly collaborates with Caitlin Clark to revitalize sports courts in Indianapolis, highlighting their commitment to community engagement and health.

SCOTUS Restores Telehealth Access to Mifepristone

The SCOTUS ruling temporarily restores telehealth access to mifepristone, impacting the pharmaceutical landscape. This article explores the implications for pharma teams.

Doceree Launches Daily Command: Transforming Pharma Brand Teams with AI

Doceree has unveiled Daily Command, an innovative AI platform designed for pharmaceutical brand teams. This article explores its implications for the industry.

Doceree Launches Daily Command: Transforming Pharma Brand Strategies

Doceree has unveiled Daily Command, an AI platform designed for pharma brand teams. This innovation promises to reshape how pharmaceutical companies strategize and execute their marketing efforts.

Roche's ctDNA-Guided Approach: A Breakthrough in Bladder Cancer Treatment

Roche's innovative ctDNA-guided approach for Tecentriq in post-surgical bladder cancer has received significant recognition. This article delves into its implications for the pharma sector.

Analysis of BMS-Hengrui's $15B Deal and Its Implications

This article analyzes the recent $15B deal between BMS and Hengrui, the impact of Takeda's layoffs, and Daiichi's strategic focus on oncology.

Navigating Manufacturing Hurdles in Biopharma

As biologics take center stage in biopharma, manufacturers face significant hurdles that impact new product launches. This article explores the implications for industry stakeholders.

SCOTUS Restores Telehealth Access to Mifepristone: Implications for Pharma

The recent SCOTUS ruling temporarily restores telehealth access to mifepristone, impacting pharmaceutical strategies and market dynamics. This article explores the implications for pharma teams.

Manufacturing Challenges in Biopharma: Navigating the New Landscape

As biologics increasingly dominate biopharma pipelines, new manufacturing challenges are emerging. This article explores the implications for industry stakeholders.

Rusan Pharma Secures GMP Clearance from Japan's PMDA

Rusan Pharma has achieved a significant milestone by securing GMP clearance from Japan's PMDA, marking a pivotal moment for the company. This article explores the implications of this regulatory update for the pharmaceutical industry.

Reckitt Benckiser Layoffs Hit NJ: Mucinex Maker Cuts Jobs

Reckitt Benckiser, the company behind Mucinex, has announced further layoffs in New Jersey. This move signals ongoing restructuring within the pharmaceutical giant and reflects broader industry trends.

Reckitt Benckiser Layoffs: Mucinex Maker Cuts Jobs in NJ

Reckitt Benckiser, the company behind Mucinex, has announced further layoffs in New Jersey. This move signals ongoing strategic adjustments within the pharmaceutical giant.

Auvelity FDA Approval: New MDD Treatment Option

The FDA has approved Auvelity, a new oral antidepressant from Axsome Therapeutics, offering a novel mechanism of action for adults with major depressive disorder (MDD). This landmark approval signifies a significant advancement in depression treatment options.

SAKIGAKE Designation Japan: Bispecific Antibodies for Leukemia Status 2026

This article delves into the SAKIGAKE Designation in Japan for bispecific antibodies, focusing on their potential to transform leukemia treatment by 2026.